Copyright
©The Author(s) 2025.
World J Methodol. Dec 20, 2025; 15(4): 106148
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.106148
Published online Dec 20, 2025. doi: 10.5662/wjm.v15.i4.106148
Table 3 Role of probiotics in the maintenance of remission in Crohn’s disease
Ref. | Type of study | Number (n) | Findings |
Garcia et al[23] | RCT | Treatment group (n = 14). Control group (n = 17) | Improvement in clinical activity |
Bourreille et al[24] | DB-RCT | Treatment group (n = 80). Control group (n = 79) | No benefits of probiotics |
Bjarnason et al[25] | RCT | Treatment group (n = 33). Control group (n = 29) | No benefits of probiotics |
Marteau et al[26] | DB RCT | Treatment group (n = 48). Control group (n = 50) | No benefits of probiotics |
- Citation: Singh JP, Aleissa M, Chitragari G, Drelichman ER, Mittal VK, Bhullar JS. Uncovering the role of microbiota and fecal microbiota transplantation in Crohn’s disease: Current advances and future hurdles. World J Methodol 2025; 15(4): 106148
- URL: https://www.wjgnet.com/2222-0682/full/v15/i4/106148.htm
- DOI: https://dx.doi.org/10.5662/wjm.v15.i4.106148